Search - tctmd.com

Displaying 1 - 2 of 2

Sort: Relevancy | Date

Quality-of-Life Measures as Valid Clinical Surrogates and Primary Endpoints in Randomized Trials: Why the Resistance?

Presentation TCT 2016

Quality-of-Life Measures as Valid Clinical Surrogates and Primary Endpoints in Randomized Trials: Why the Resistance?

Presenter: Roxana Mehran, Pascal Vranckx, John A. Spertus

October 30, 2016

Quality-of-Life Measures and Cost-Effectiveness After TAVR

Presentation TVT 2012

Quality-of-Life Measures and Cost-Effectiveness After TAVR

Presenter: David Cohen

June 04, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.